Silo Pharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Silo Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2023.
  • Silo Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$115K.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$471K, a 110% decline from 2022.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.94M, a 30.2% increase from 2021.
  • Silo Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $3.79M, a 77.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$471K -$5.41M -110% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 $4.94M +$1.15M +30.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $3.79M +$1.66M +77.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $2.13M +$1.75M +458% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $383K +$363K +1867% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-17
2018 $19.5K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2013 $2.19M +$2.17M +10860% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-31
2012 $20K +$19.4K +3378% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 $575 Jan 1, 2011 Dec 31, 2011 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.